LOADING
Comparing Thermo Fisher Scientific (TMO) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TMO | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $176.0B | $232.7B |
| P/E Ratio | 26.0 | 22.8 |
| Forward P/E | 19.0 | 19.7 |
| PEG Ratio | 1.56 | 0.90 |
| EPS | $18.19 | $9.69 |
| Revenue Growth (YoY) | 6.2% | -3.5% |
| Profit Margin | 15.1% | 22.3% |
| Return on Equity | 13.5% | 36.1% |
| Dividend Yield | 0.38% | 1.68% |
| Beta | 0.87 | 1.60 |
| 52-Week High | $642.71 | $258.96 |
| 52-Week Low | $384.06 | $121.54 |
| Volume | -- | -- |
Qualcomm Inc is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Qualcomm Inc offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.